Literature DB >> 9593871

MK801-a neuroprotectant in rat hypertensive eyes.

P Chaudhary1, F Ahmed, S C Sharma.   

Abstract

Excitatory synaptic transmission in the mammalian CNS and retina is mainly mediated through l-glutamate. The effect of MK-801, a non-competitive antagonist of the NMDA subtype of glutamate receptor was studied on rat retinal ganglion cells in hypertensive eyes. MK-801 was administered intraperitoneally to the first group, 1 day before the increase, and in the second group, 2 days after the intraocular pressure (IOP) elevation. Phosphate-buffered saline was administered to the control group. Animals were sacrificed 2 and 4 weeks post-IOP increase. The retinal ganglion cells were counted and compared between control (right) and experimental (left) eyes. The data presented here suggests that MK-801 has neuroprotective properties. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593871     DOI: 10.1016/s0006-8993(98)00212-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.

Authors:  Li Guo; Thomas E Salt; Annelie Maass; Vy Luong; Stephen E Moss; Fred W Fitzke; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

Review 2.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

Review 3.  Protecting retinal ganglion cells.

Authors:  T Z Khatib; K R Martin
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

4.  Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Authors:  H Schori; J Kipnis; E Yoles; E WoldeMussie; G Ruiz; L A Wheeler; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells.

Authors:  Shinichiro Saito; Masaaki Ohashi; Akira Naito; Yasuhiro Fukaya; Yasuyuki Suzuki; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

Review 6.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers.

Authors:  Jorge I Calzada; B Eric Jones; Peter A Netland; Dianna A Johnson
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

Review 8.  [Mechanisms of neuroprotection against glaucoma].

Authors:  T Mittag; K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

9.  The selective vulnerability of retinal ganglion cells in rat chronic ocular hypertension model at early phase.

Authors:  Xue-Gang Luo; Kin Chiu; Flora H S Lau; Vincent W H Lee; Ken K L Yung; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 10.  Rodent models of glaucoma.

Authors:  Thomas V Johnson; Stanislav I Tomarev
Journal:  Brain Res Bull       Date:  2009-04-18       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.